Interestingly, the anti-TIM-3 antibody inhibited the intracranial growth of human glioblastoma cell line U87MG in nude mice, suggesting that the antitumor effects of this anti-TIM-3 antibody may not be completely dependent on evoking or enhancing an immune response. The gene discussed is HAVCR2; the disease is glioblastoma.